Antidepressants in Dementia - Less Benefit, More Side Effects

by Dr. Nithin Jayan on  August 05, 2011 at 12:04 PM Health In Focus
  •   Print
  •   Share
  •   Comments
  •  Text 
Antidepressants may provide little benefit in dementia patients suffering from depression, a study suggests. They appear to increase adverse effects instead! Clinicians may thus "reframe" the way they treat the condition, and “reconsider routine prescription of antidepressants”.

With more than 35 million people affected worldwide, the global burden that dementia imposes amounts to 1% of global gross domestic product every year. Dementia has a devastating effect on those affected and their families. Depression is one of the commonest conditions associated with dementia - 20% of people with dementia suffer depression. The class of drugs called antidepressants is widely prescribed for the ailment. The fact that this treatment is not proven scientifically is a source of great distress.

The efficacy and safety of two of the most commonly prescribed antidepressants namely sertraline and mirtazapine in dementia patients were assessed in a recent study in England. 326 elderly patients were involved in the programme. The results were negative and the study stresses on second thoughts before prescribing antidepressants for depression in dementia.

Treatment with these drugs was found to be no better than placebo. The side effects add to the dilemma. While sertraline was notorious for causing nausea, drowsiness and sedation were the most common side effects produced by mirtazapine.

The research suggests that clinicians should reconsider the use of these agents in dementia. Even three months of drug usage did not bring any significant reduction in depression. A number of treatment-associated adverse events were reported instead.

The current study which is perhaps the largest trial of its kind is not devoid of flaws, but it is claimed to the most reliable one till date.

Reference: Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial; Sube Banerjee et al; The Lancet 2011.

Source-Medindia

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Senior Health Center

Health In Focus News

» Surgical Treatments of Male Stress Urinary Incontinence » Bullied Early Adolescents are Prone to Self Harm: BMJ Study
» Novel Artificial Devices in the Treatment of Male Urinary Incontinence » Chances of Birth Defects With Assisted Reproductive Technologies
» Antioxidant Food Database » Hypnosis Can Help Ease Pain
» Lenalidomide-based Regimens for Multiple Myeloma » Occurrence of Non-Communicable Diseases in Prisoners - An Overview
Read More >>